The 110mcg strength of Asmanex Twisthaler (mometasone furoate inhalation powder, from Schering-Plough), an inhaled corticosteroid, is now available for the maintenance treatment of asthma in patients ...
Asmanex Twisthaler has been launched by Schering-Plough as therapy in the control and management of mild, moderate or severe persistent asthma in Asmanex Twisthaler has been launched by ...
The FDA has approved Asmanex Twisthaler (mometasone furoate inhalation powder, from Schering-Plough) 110 mcg for the maintenance treatment of asthma as a preventive therapy in patients 4-11 years of ...
April 14, 2005 -- The U.S. Food and Drug Administration (FDA) has approved mometasone furoate inhalation powder for the maintenance treatment of asthma as prophylactic therapy in patients aged 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback